Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions

AAPS PharmSciTech. 2014 Feb;15(1):230-6. doi: 10.1208/s12249-013-0050-2. Epub 2013 Dec 3.


The aim of the present work was the investigation of robustness and reliability of drug release from 50 to 400 mg quetiapine extended release HPMC matrix tablets towards mechanical stresses of biorelevant intensity. The tests were performed under standard conditions (USP apparatus II) as well as under simulated gastrointestinal stress conditions. Mechanical stresses including pressure and agitation were applied by using the biorelevant dissolution stress test apparatus as it has been introduced recently. Test algorithms already established in previous studies were applied to simulate fasting gastrointestinal conditions. The dissolution experiments demonstrated striking differences in the product performance among standard and stress test conditions as well as dose strengths. In USP apparatus II, dissolution profiles were affected mainly by media pH. The dissolution experiments performed in biorelevant dissolution stress test device demonstrated that stress events of biorelevant intensity provoked accelerated drug release from the tablets.

MeSH terms

  • Delayed-Action Preparations / chemistry*
  • Dibenzothiazepines / chemistry*
  • Hydrogen-Ion Concentration
  • Quetiapine Fumarate
  • Solubility
  • Stress, Mechanical
  • Tablets / chemistry*


  • Delayed-Action Preparations
  • Dibenzothiazepines
  • Tablets
  • Quetiapine Fumarate